Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0Y7WU
|
||||
Former ID |
DNC007228
|
||||
Drug Name |
6-(4-methoxyphenyl)-4-morpholino-2H-pyran-2-one
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528738] | ||
Structure |
Download2D MOL |
||||
Formula |
C16H17NO4
|
||||
Canonical SMILES |
COC1=CC=C(C=C1)C2=CC(=CC(=O)O2)N3CCOCC3
|
||||
InChI |
1S/C16H17NO4/c1-19-14-4-2-12(3-5-14)15-10-13(11-16(18)21-15)17-6-8-20-9-7-17/h2-5,10-11H,6-9H2,1H3
|
||||
InChIKey |
PRPSUNXAZLZCBS-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | DNA-dependent protein kinase catalytic subunit | Target Info | Inhibitor | [528738] | |
KEGG Pathway | Non-homologous end-joining | ||||
Cell cycle | |||||
NetPath Pathway | IL1 Signaling Pathway | ||||
Reactome | Nonhomologous End-Joining (NHEJ) | ||||
References | |||||
Ref 528738 | J Med Chem. 2007 Apr 19;50(8):1958-72. Epub 2007 Mar 20.Pyranone, thiopyranone, and pyridone inhibitors of phosphatidylinositol 3-kinase related kinases. Structure-activity relationships for DNA-dependent protein kinase inhibition, and identification of the first potent and selective inhibitor of the ataxia telangiectasia mutated kinase. | ||||
Ref 528738 | J Med Chem. 2007 Apr 19;50(8):1958-72. Epub 2007 Mar 20.Pyranone, thiopyranone, and pyridone inhibitors of phosphatidylinositol 3-kinase related kinases. Structure-activity relationships for DNA-dependent protein kinase inhibition, and identification of the first potent and selective inhibitor of the ataxia telangiectasia mutated kinase. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.